There some things you can do to treat a sebaceous cyst at home. Zeichner recommends a regimen of familiar acne fighters. Finally, hydrocortisone cream helps reduce inflammation. Topical hydrocortisone cream can effectively reduce the swelling, redness, and discomfort associated with stubborn, under the skin pimples. Generally, hydrocortisone cream is applied directly to an active pimple, where it reduces the overall inflammation of the blemish. Topical treatments are available through a prescription, or readily available over the counter.
When combined, hydrocortisone works to reduce inflammation and redness by calming the site of the breakout, while the Benzoyl Peroxide works to reduce acne-causing bacteria. Benzoyl Peroxide can be quite drying and cause irritation, so by combining it with Hydrocortisone, it helps to alleviate some of that redness and irritation. Cystic acne is a more severe form of acne. It manifests deep underneath the skin, appearing as red, hard, tender bumps and pus-filled cysts.
While the aforementioned trick is helpful, there's a little more you should know if you're thinking of using hydrocortisone to treat pimples. Here's what to keep in mind before trying it yourself, according to a pro. It's a steroid that's often used to treat a variety of skin issues like itching, swelling, allergies, redness, and anything that might cause discomfort on the skin's surface.
It's common for dermatologists to administer hydrocortisone shots to patients to help relieve red, irritated pimples, as topical hydrocortisone creams won't prevent breakouts or eliminate the underlying cause of acne. Again, hydrocortisone creams aren't official acne treatments , so you should talk to a dermatologist about effective alternatives if you're dealing with blackheads and whiteheads. That said, hydrocortisone can be bought over the counter and safely used to treat inflamed, irritated pimples so long as you're using a small amount of the product at a time.
Irwin said. Irwin also noted that if you're using a hydrocortisone cream and you don't see results after three days, it's probably not going to work, and you should contact a dermatologist for something more effective. As mentioned before, one risk you take when using a hydrocortisone product is that, even though it may be reducing redness or irritation, some users who apply too much of the product too often may also experience what Dr.
Irwin calls a "rebound effect" that causes skin discoloration and makes the blemish appear even redder than before. The bottom line is that, while hydrocortisone can be used to treat blemishes, your use of it should be very limited, and you should always try to consult a professional before applying a new treatment to your skin. What Is Hydrocortisone, Anyway? You May Also Like. Beauty Trends. Beauty Tips.
Medications and supplement use, social history including tobacco and illicit drug use, menstrual history i. A complete review of systems should be conducted to seek symptoms of hyperandrogenism or other endocrinology disorders.
Signs and symptoms of hyperandrogenism include acne, hirsutism, seborrhea, androgenetic alopecia, amenorrhea, oligomenorrhea, virilization, clitoromegaly, infertility, polycystic ovaries, increased muscle mass, and decreased breast size Harper, , Lolis et al. Hirsutism is highly associated with elevated serum levels of free testosterone.
Given that hair removal may obscure a clinician recognition of hirsutism, patients should be asked about the nature and frequency of hair removal practices as well as the locations of hair overgrowth. If patients exhibit signs or symptoms of hyperandrogenism, a thorough endocrinologic work-up should be initiated.
The differential diagnosis of acne in adult female patients is detailed in Table 1 , along with distinguishing characteristics. In addition, underlying systemic causes for acne including hyperandrogenism should be assessed. Causes of drug-induced acne are detailed in Table 2. Hughes et al. Kim and Kim, Routine cultures are not done unless gram-negative folliculitis or Staphylococcus aureus folliculitis are considered in the differential diagnosis Zaenglein et al.
Gram-negative folliculitis presents as monomorphic eruptive pustules in the perioral, beard, and neck distribution and typically in the setting of prolonged oral tetracycline use Zaenglein et al. Gram-negative folliculitis is caused by gram-negative microbes such as Klebsiella and Serratia and is treated with isotretinoin.
Microbe-directed therapy may be considered given the clinical setting and individual patient characteristics. The American Academy of Dermatology AAD working group on the management of acne vulgaris only recommends microbiologic testing for those who exhibit acne-like lesions that are suggestive of gram-negative folliculitis and not otherwise Zaenglein et al. The role of androgens in acne is well established. Endocrine testing is only needed in patients who have other signs or symptoms of hyperandrogenism.
Significant virilization suggests disorders of severe insulin resistance, androgen-secreting tumors, and androgenic substance abuse Azziz et al. A laboratory test panel to screen for PCOS includes free and total testosterone, dehydroepiandrosterone sulfate, androstenedione, luteinizing hormone, and follicle-stimulating hormone Azziz et al. The differential diagnosis of PCOS includes thyroid disease, prolactin excess, nonclassical congenital adrenal hyperplasia, and other rare endocrinology disorders Zaenglein et al.
Women who are already prescribed oral contraceptive medications and display additional signs of androgen excess should have similar testing done, although oral contraceptive pills may be beneficial to women with clinical and laboratory findings of hyperandrogenism as well as in women without these findings Zaenglein et al. An endocrinologist should evaluate patients with abnormal hormone levels. The AAD working group only recommends laboratory evaluations for patients who have acne and additional signs of androgen excess Zaenglein et al.
Table 3 shows the various treatments for patients with AV, along with the strength of recommendations from the AAD working group but modified to include pregnancy and lactation ratings. This review article focuses on topical therapies, systemic antibiotic medications, isotretinoin, and novel therapies under development. A more complete discussion on the use of hormonal agents can be found in an article by Trivedi et al.
AAD Working Group strength of recommendations for the management and treatment of patients with acne vulgaris a. American Academy of Dermatology Working Group treatment algorithm for the management of adolescents and young adults with acne vulgaris a. The treatment of acne is challenging and often chronic, with high rates of failure and numerous choices. A good therapeutic relationship with the patient is important to establish as well as setting realistic treatment goals.
Frequent evaluations i. Patient counseling is critical, especially to establish a time course for medication efficacy and discuss future therapeutic modalities in case of treatment failure or intolerability. The central tenets of acne management as displayed in Table 4 should be followed in the treatment of adult female patients. However, additional considerations exist that should be kept in mind during treatment. Women over the age of 25 years tend to have high rates of treatment failure Kamangar and Shinkai, Suspicion of an underlying endocrinology disorder should be heightened if a recurrence of acne appears shortly after treatment with isotretinoin Lowenstein, Women of childbearing potential should also be asked about their plans for reproduction, and treatment should be tailored for safety, whether the patients are actively trying to conceive, pregnant, or lactating Table 3.
Among the physiologic changes of pregnancy is a rise in serum androgen levels Bozzo et al. Published information on the effects of acne medications on the developing fetus or breastfeeding infant is very limited Kong and Tey, Pregnancy and lactation are often part of the exclusion criteria in clinical trials; therefore, available information on medication-related teratogenicity and effects on lactation are often derived from case reports and animal studies.
The most widely used pregnancy classification is the U. However, this classification system has been criticized for its large focus on animal data and frequent classification of new medications as class B safe in pregnancy; Kong and Tey, as well as its excessive simplicity and lack of information about the severity and nature of possible side effects on the fetus Public Affairs Committee of the Teratology Society, Summary of U.
Food and Drug Administration categories for medication use in pregnancy. The AAP system stratifies drugs into three categories: those that should be used with concern; those with unknown effects but may be of concern; and those that are generally compatible with breastfeeding American Academy of Pediatrics Committee on Drugs, The LactMed system is a peer-reviewed database that provides comprehensive information about drugs that may be used in mothers who breastfeed including serum drug levels, adverse effects on infants, and alternative drugs to consider U.
National Library of Medicine, Given the lack of data, a lack of unified drug classifications for women who are pregnant or lactating, and the serious risk of teratogenicity, clinicians tend to take a conservative approach to treating acne in this group of women.
Additionally, primary practitioners and dermatologists have a popular view that acne is a cosmetic issue, which further leads clinicians to choose less effective treatments or even withhold treatment during pregnancy and lactation Kong and Tey, Topical therapies are considered one of the mainstay treatments for patients with mild-to-moderate acne Nast et al.
These topical agents are available over the counter and by prescription. More recently, several topical therapy combinations have been developed to treat patients with acne. Generally, topical agents are considered safer than oral medications for use in women who are pregnant or lactating because systemic availability of the drug is lower. Some topical medications do not even have a pregnancy category because systemic absorption is generally considered minimal unless use is extensive, intensive, or prolonged Meredith and Ormerod, Commonly used topical treatments for patients with acne include benzoyl peroxide BP , salicylic acid SA , antibiotic medications, combination antibiotic medications with BP, retinoid medications, retinoid with BP, retinoid with antibiotic medication, azelaic acid, and sulfone agents Zaenglein et al.
BP is commonly used to treat patients with acne and is available in a variety of strengths 2. BP is a comedolytic, keratolytic, anti-inflammatory agent with antimicrobial properties. BP is bactericidal mainly against P. The addition of BP to antibiotic therapy enhances results and may reduce antibiotic resistance development Zaenglein et al. Topical BP in varying formulations may be used 1 to 3 times daily as tolerated. The use of BP is limited by concentration-dependent irritation, staining and bleaching of fabric, and uncommon contact allergy Zaenglein et al.
Lower concentrations 2. Some clinicians are reluctant to prescribe BP concurrently with topical tretinoin due to the belief that BP may cause oxidation and degradation of the tretinoin molecule and thereby reduce its effectiveness. However, BP-induced degradation of tretinoin does not apply to all topical tretinoin formulations and multiple studies show the stability of tretinoin concentration and safety when using micronized tretinoin gel 0.
SA is a comedolytic agent that is available over the counter in 0. SA is generally well tolerated by patients, but its efficacy in acne is limited Shalita, , Shalita, BP and SA are the most widely used over-the-counter, topical, acne treatments and are often used in combination. SA may be applied 1 to 3 times daily as tolerated. Topical antibiotic medications are thought to accumulate in the follicle and may work through both anti-inflammatory and antibacterial effects Mills et al.
Due to increasing antibiotic resistance, monotherapy with topical antibiotic medications in the management of acne is not recommended. Topical antibiotic medications are best used in combination with BP Zaenglein et al. The main topical antibiotic medications are clindamycin and erythromycin.
Clindamycin is available in a gel, lotion, pledget, or topical solution and has been assigned FDA pregnancy category B. The recommended dosing is an application of a thin layer once daily. Erythromycin is available as a gel, solution, ointment, pledget, or thin film. Oral and topical erythromycin formulations are both classified as FDA category B. Topical erythromycin is less efficacious in patients with acne than clindamycin because of P. Combination agents may enhance compliance with treatment regimens Zaenglein et al.
Topical erythromycin is usually administered 1 to 2 times daily. Topical retinoid medications are vitamin A—derivative prescription agents Bradford and Montes, , Krishnan, , Lucky et al. Topical retinoid medications are often used as first-line treatment for patients with mild-to-moderate acne, especially when the acne is mainly comedonal. Retinoid therapy is comedolytic and resolves the precursor microcomedone lesion.
Retinoid medications are also anti-inflammatory and work in combination with other topical agents for all acne variants Zaenglein et al. Topical retinoid treatments are the mainstay in the maintenance of clearance after discontinuation of oral therapy Zaenglein et al. The recommended dosing is application of a thin layer once daily. Three topical retinoid medications are used in the treatment of patients with acne: tretinoin 0. Generally, therapy is initiated best every other day and then increased to daily as tolerated.
The proper amount to use e. With any of the topical retinoid treatments, higher concentrations are more efficacious but have greater side effects Christiansen et al. Additionally, topical retinoid medications increase the risk of photosensitivity so sunscreen lotion should be used concurrently.
Generic formulations of tretinoin are typically not photostable and should be applied in the evening. Coadministration of BP with tretinoin also leads to oxidation and inactivation of tretinoin; therefore, these agents should be applied at different times i.
The micronized tretinoin formation as well as adapalene and tazarotene do not have similar restrictions. Available combination agents that contain retinoid include adapalene 0. In addition, clindamycin phosphate 1. There are conflicting reports on the safety of topical retinoid medications in women who are pregnant or lactating. Isolated cases have been reported of congenital malformations that were temporally associated with the use of these agents Autret et al. However, a large observational prospective study of women who were exposed to a topical retinoid during their first trimester were compared with women in the control group and no statistically significant differences in the rates of spontaneous abortions and minor or major birth defects were detected Panchaud et al.
A formal consensus on the safety of topical retinoid medications during pregnancy is lacking van Hoogdalem, Additionally, manufacturers advise that these agents should not be used during pregnancy. Patients should be counseled on these pregnancy risks when initiating retinoid treatment if they desire pregnancy. Azelaic acid acts as a comedolytic, antimicrobial, and anti-inflammatory agent Strauss et al.
Azelaic acid should be used with caution in patients with sensitive skin due to side effects that include redness, burning, and irritation. Azelaic acid should also be used with caution in patients with Fitzpatrick skin types IV or greater because of its potential lightening effect Cunliffe and Holland, , Katsambas et al. However, because of this side effect, azelaic acid is a useful adjunctive in acne treatment because it aids in the treatment of postinflammatory dyspigmentation.
The dosing recommendation is application of a thin film to the affected areas twice daily. Azelaic acid is categorized as FDA pregnancy class B because animal studies have shown no teratogenicity, but data on humans are not available. Data only show modest-to-moderate efficacy in the reduction of inflammatory acne lesions Draelos et al.
Dapsone has a poorly understood mechanism in the treatment of patients with acne and its ability to kill P. Similar to other topical antibiotic treatments, dapsone is thought to work as an anti-inflammatory agent. The recommended dosing is application of a thin layer twice daily.
Dapsone should be used cautiously in combination with BP because coapplication may cause reversible, orange-brown discoloration of the skin, which can be brushed or washed off. Systemic absorption of topical dapsone is thought to be minimal so baseline glucosephosphate dehydrogenase testing is not required.
Topical dapsone is classified as FDA pregnancy category C. The following topical agents lack evidence-based data for their use in patients with acne but have been demonstrated to be effective in clinical practice: sodium sulfacetamide Lebrun, , Tarimci et al. Oral antibiotic medications are commonly prescribed as second-line therapy for patients with mild-to-moderate acne that is not adequately controlled with topical agents alone and are a mainstay of acne treatment in patients with moderate-to-severe inflammatory acne.
Oral antibiotic agents should be used in combination with a topical retinoid and BP if tolerated Gold et al. Given the rise in antibiotic resistance, monotherapy with oral antibiotic medications is strongly discouraged Moon et al. The Centers for Disease Control and Prevention has stressed antibiotic stewardship and limit antibiotic use to the shortest possible duration, ideally months Zaenglein et al. Limiting systemic antibiotic use may also reduce the risk of inflammatory bowel disease for tetracyclines; Margolis et al.
Penicillin, erythromycin, and cephalosporin are thought to have the best safety profile during pregnancy Hernandez-Diaz et al. Of note, there is limited evidence on the administration of antibiotic agents and the potential impact on the effectiveness of oral contraceptive pills Hoffmann et al. Although a large epidemiological study that was conducted in the United States showed that there is no association between concomitant antibiotic use and the risk of breakthrough pregnancy among oral contraceptive pill users Guengerich, , other studies have shown a potential relationship Back et al.
There are three categories of antibiotic agents that range from those that are likely to reduce the effectiveness of OCPs rifampin , those that are associated with OCP failure in three or more reported cases ampicillin, amoxicillin, metronidazole, and tetracycline , and those that were associated with OCP failure in at least one case report cephalexin, clindamycin, dapsone, erythromycin, griseofulvin, isoniazid, phenoxymethylpenicillin, talampicillin, and trimethoprim; Miller et al.
A conservative approach is the recommend use of a second form of contraception while taking a systemic antibiotic agent Zhanel et al. Tetracycline agents have notable anti-inflammatory effects Zaenglein et al.
Pseudotumor cerebri is a rare phenomenon that is associated with the use of tetracycline agents Zaenglein et al. Tetracycline medications including minocycline and doxycycline are classified as FDA pregnancy category D. Tetracycline agents should not be used during pregnancy because use during the second and third trimester is known to cause discoloration of the teeth and bones. However, there is no firm evidence that first-trimester use is associated with major birth defects Kong and Tey, , Meredith and Ormerod, Cases of maternal liver toxicity that is associated with the use of tetracycline agents during the third trimester have been reported Hale and Pomeranz, , Rothman and Pochi, , Wenk et al.
Although there is a theoretical risk of bone and teeth malformation if tetracycline is administered during lactation, low concentrations of neonatal absorption are expected because of its strong binding with calcium ions in breast milk.
Tetracycline is generally considered safe for use during breast feeding Spencer et al. Doxycycline appears to be effective for patients with AV in the 1. Subantimicrobial dosing of doxycycline i. Issues to consider when prescribing doxycycline include the fact that doxycycline is more photosensitizing than minocycline Zaenglein et al. To mitigate these side effects, patients should be counseled to use sunscreen lotion and other photoprotective measures to decrease the risk of sunburns, take doxycycline with a meal or a full glass of water, and not take doxycycline less than 1 hour prior to bedtime.
Additionally, absorption is decreased with the concomitant intake of iron and calcium. The hyclate version of doxycycline tends to have greater gastrointestinal side effects compared with the monohydrate form. Doxycycline is primarily metabolized by the liver and can be used safely in most patients with renal disease Zaenglein et al.
Previously, treatment with minocycline was thought to be superior to doxycycline in reducing P. However, a recent Cochrane review found that minocycline was effective to treat patients with AV but was not superior to other antibiotic medications Garner et al.
For practical purposes, minocycline is generally dosed at 50 to mg twice daily. Compared with doxycycline, minocycline tends to have lower rates of gastrointestinal side effects but is associated with tinnitus, dizziness, and pigment deposition within the skin, mucous membranes, and teeth. Minocycline-associated pigmentation is more common in patients who take higher doses for longer periods of time Zaenglein et al.
Rare, serious, immune-mediated events have also been associated with minocycline including drug-induced hypersensitivity syndrome or a drug reaction with eosinophilia and systemic symptoms, drug-induced lupus, and other hypersensitivity reactions Kermani et al.
Macrolide medications including erythromycin and azithromycin have been used in the treatment of patients with acne but recently have fallen out of favor as first-line treatment. Macrolide agents are considered alternative therapy when traditional antibiotic medications cannot be used.
As with tetracycline, macrolide has some anti-inflammatory properties but the specific mechanism of action in acne is unknown. The most common side effect is gastrointestinal disturbances Zaenglein et al. Macrolide medications occasionally can cause cardiac conduction abnormalities and rarely cause hepatotoxicity Zaenglein et al. Erythromycin is the traditional oral antibiotic medication of choice when a systemic antibiotic treatment is needed for acne while a patient is pregnant Hale and Pomeranz, , Koren et al.
Due to increasing bacterial resistance, erythromycin should be combined with a topical preparation such as BP Meredith and Ormerod, Due to the differences in absorption, mg erythromycin ethyl succinate produces the same serum levels as mg erythromycin base or stearate. For the erythromycin base, dosing ranges from to mg twice daily. For erythromycin ethyl succinate, dosing ranges from to mg twice daily.
Oral erythromycin is classified as FDA pregnancy category B. Erythromycin is more commonly used during pregnancy to treat other infections, which resulted in larger retrospective studies on pregnancy outcomes Romoren et al. Although erythromycin is largely considered safe for use during pregnancy, reports of fetal cardiac malformation exist Kallen et al. Azithromycin is an azalide antibiotic agent that is derived from erythromycin Meredith and Ormerod, and tends to be better tolerated compared with erythromycin Kong and Tey, Azithromycin has been studied in varying doses from 3 times a week to 4 days a month with varying efficacy in patients with AV and all trials used pulse-dosing regimens Antonio et al.
Trial doses have included mg once daily for 4 consecutive days per month for 2 consecutive months Babaeinejad et al. One study from showed that azithromycin is as effective to treat patients with AV as doxycycline Kus et al. A more recent, randomized, controlled trial that compared treatment with azithromycin 3 days per month to daily doxycycline showed the superiority of doxycycline Ullah et al.
As with erythromycin, azithromycin is classified as FDA pregnancy category B. The usual dosing for patients with AV is one double-strength tablet twice daily. These risks are increased among women who do not use a multivitamin that contains folic acid Hernandez-Diaz et al. Additionally, exposure during the third trimester of pregnancy is small for gestational age infants as well as associated with hyperbilirubinemia Ho and Juurlink, Penicillin and cephalosporin are well established as safe for use during pregnancy and lactation Hale and Pomeranz, However, they are rarely used to treat patients with acne because information with regard to efficacy is sparse.
Penicillin and cephalosporin can be used as an alternative to conventional antibiotic medications, especially during pregnancy or with allergies to other classes of antibiotic treatments Zaenglein et al. Side effects include risk of hypersensitivity reactions that range from mild drug eruptions to anaphylaxis and gastrointestinal disturbances i.
The recommended dosing for amoxicillin is mg twice daily up to mg three times daily. Cephalosporin has in vitro activity against P. Isotretionoin is an important nonhormonal and nonantimicrobial treatment option for adult women with acne Gollnick et al.
Oral isotretinoin is FDA-approved for the treatment of severe recalcitrant AV but can also be used to treat patients with moderate acne that is either treatment-resistant or relapses quickly after discontinuation of oral antibiotic therapy Agarwal et al. Several studies have shown that isotretinoin effectively decreases sebum production, the number of acne lesions, and acne scarring Amichai et al.
According to the AAD working group, isotretinoin is also indicated for the treatment of patients with moderate inflammatory acne that is either treatment-resistant or produces physical scarring or significant psychosocial distress Zaenglein et al. Isotretinoin is usually initiated at a starting dose of 0. In very severe cases, lower initial doses in addition to oral corticosteroid medications may be needed.
Low-dose isotretinoin 0. However, intermittent dosing is not as effective as daily dosing and exhibits higher relapse rates Agarwal et al. Absorption of isotretinoin is increased with fatty foods and isotretinoin is recommended to be taken with meals Strauss et al. The lidose formulation Absorica has absorption profiles that are not dependent on fat intake. The most prevalent side effects of isotretinoin mimic symptoms of hypervitaminosis A Zaenglein et al.
With standard dosing, these side effects resolve after discontinuation of therapy Zaenglein et al. Although many small case reports and series show that isotretinoin has no negative effect on mood, memory, attention, or executive function Alhusayen et al. Food and Drug Administration, In the FDA case series, patients recovered after isotretinoin was discontinued and had a recurrence of symptoms after reinitiating isotretinoin.
When patients were rechallenged, the time to onset of the psychiatric symptoms was on average shorter, and 10 patients had persistent psychiatric symptoms after isotretinoin discontinuation. As of December 31, , isotretinoin users worldwide have committed suicide while taking isotretinoin or within a few months of discontinuation of treatment and another patients have been hospitalized for severe depression or attempted suicide Duenwald, However, some have argued that the number of reported cases of depression among isotretinoin users is no greater than in the general population Lamberg, The AAD working group recommends that prescribing physicians monitor patients for any indication of depressive symptoms and educate patients on the potential risks of treatment with isotretinoin.
Laboratory test result monitoring for patients on isotretinoin varies widely among practitioners. Serum cholesterol, triglycerides, and transaminases are known to increase in some patients who take oral isotretinoin Bershad et al. Routine monitoring of serum lipid profiles and liver function studies are recommended to be done regularly but the interval varies Bershad et al.
Some practitioners monitor laboratory test results monthly, but others only check at baseline and after dosing changes. Hansen et al. If the findings are normal, no further testing may be required. The AAD working group did not find any evidence-based reason to warrant routine monitoring of complete blood cell counts Zaenglein et al.
Pregnancy testing is required for female patients of childbearing potential at baseline, monthly during therapy, and 1 month after completion of isotretinoin treatment. The use of oral isotretinoin during pregnancy is absolutely contraindicated FDA pregnancy category X due to its known severe teratogenicity including craniofacial, cardiac, and thymic malformations Lammer et al.
As a result of these serious effects, the manufacturers of oral isotretinoin have developed pregnancy prevention programs where preferably two forms of contraception are recommended Goodfield et al. Currently, the United States and United Kingdom require enrollment in these pregnancy prevention programs to receive oral isotretinoin. Dermatologists should counsel women that they should not become pregnant 1 month before, during, or within 1 month after completion of isotretinoin therapy.
The following therapies have limited evidence for their efficacy in the treatment of patients with AV. Some of these modalities may be helpful to treat acne scarring as well. These treatments include comedo extraction Meredith and Ormerod, , Zaenglein et al.
Many patients wish to use more natural treatments and may look to herbal and alternative agents for treatment. Although most of these agents are generally well tolerated, there are limited data with regard to efficacy and safety. Additionally, the specific ingredients, concentrations, and potential adulteration with other unwanted chemicals is not well regulated and sometimes cannot be confirmed. These complementary and alternative therapies include tea tree oil Bassett et al.
Other complementary and alternative medicines Fox et al. New therapies to treat patients with AV continue to be developed. Many of these new therapies are in various stages of testing, and although the ultimate efficacy is difficult to predict, preliminary studies show promising results. Oral minocycline has been shown to be effective in the treatment of patients with AV; however, systemic side effects including abnormal mucocutaneous pigmentation and autoimmune reactions may limit its use Kircik, , Smith and Leyden, The significant reduction in lesions were observed as early as week 3 and persisted until the end of the study at week Treatment was well tolerated and safe with no drug-related systemic side effects or serious adverse events.
Nitric oxide NO has been shown to have broad-spectrum antimicrobial, wound-healing, and immunomodulatory properties Friedman and Friedman, , Martinez et al. Qin et al. Both concentrations were safe and well-tolerated by patients. Systemic anti-androgens such as spironolactone and combination oral contraceptive medications can be used in the effective treatment of patients with AV Kong and Tey, , Meredith and Ormerod, , Thiboutot and Chen, , Zaenglein et al.
However, systemic use of anti-androgens is limited to women who wish to conceive or have other endocrine disorders or contraindications Chen et al. A topical anti-androgen treatment has not been made available for use to date. A myriad of treatment choices is available to treat adult female patients with acne. A relatively limited number of options are available for the management of acne during pregnancy and lactation.
However, the level of evidence on the safety of any therapies during pregnancy and lactation is low. National Center for Biotechnology Information , U. Int J Womens Dermatol. Published online Dec Paller , MD. Author information Article notes Copyright and License information Disclaimer. Tan: ude. Published by Elsevier Inc. This article has been cited by other articles in PMC. Abstract This review focuses on the treatment options for adult female patients with acne.
Introduction Acne vulgaris AV is a disease of the pilosebaceous unit that causes noninflammatory lesions open and closed comedones , inflammatory lesions papules, pustules, and nodules , and varying degrees of scarring. Pathogenesis Four key pathogenic processes lead to the formation of acne lesions: alteration of follicular keratinization that leads to comedones; increased and altered sebum production under androgen control; follicular colonization by Propionibacterium acnes ; and complex inflammatory mechanisms that involve both innate and acquired immunity Williams et al.
Clinical presentation Acne in women can occur at any age and with varying degrees of severity. Open in a separate window. Figure 1. Comedones with post-inflammatory hyperpigmentation. Figure 2. Inflammatory papules and pustules. Figure 3. Acne Nodules and Cysts. Evaluation considerations The evaluation of any patient with acne should include a thorough medical history and physical examination.
Table 1 Differential diagnosis of acne vulgaris. Table 2 Causative agents of drug-induced acneiform eruptions. Class of agent Examples Hormones Corticosteroids and corticotropin Androgens and anabolic Steroid medications Hormonal contraceptive medications Neuropsychotherapeutic drugs Tricyclic antidepressant medications Lithium Antiepileptic drugs Aripiprazole Selective serotonin reuptake inhibitors Vitamins Vitamins B1, B6, and B12 Cytostatic drugs Dactinomycin actinomycin D Immunomodulating molecules Cyclosporine Sirolimus Antituberculosis drugs Isoniazid Rifampin Ethionamide Halogens Iodine Bromine Chlorine Targeted therapies Epidermal growth factor receptor inhibitors Multitargeted tyrosine kinase inhibitors Vascular endothelial growth factor inhibitor Proteasome inhibitor Tumor necrosis factor alfa inhibitors Histone deacetylase inhibitor.
Further testing Microbiologic testing P. Endocrine testing The role of androgens in acne is well established. Treatment of acne vulgaris Table 3 shows the various treatments for patients with AV, along with the strength of recommendations from the AAD working group but modified to include pregnancy and lactation ratings.
Table 3 AAD Working Group strength of recommendations for the management and treatment of patients with acne vulgaris a. The strength of the recommendation was ranked as follows: A. Recommendation based on consistent and good-quality patient-oriented evidence; B. Recommendation based on inconsistent or limited-quality patient-oriented evidence; C. Recommendation based on consensus, opinion, case studies, or disease-oriented evidence.
Good-quality, patient-oriented evidence; II. Limited-quality, patient-oriented evidence; III. Other evidence including consensus guidelines, opinion, case studies, or disease-oriented evidence. National Library of Medicine. Table 4 American Academy of Dermatology Working Group treatment algorithm for the management of adolescents and young adults with acne vulgaris a. BP, benzoyl peroxide. Treatment of acne vulgaris in adult women The central tenets of acne management as displayed in Table 4 should be followed in the treatment of adult female patients.
Treatment of acne vulgaris during pregnancy and lactation Women of childbearing potential should also be asked about their plans for reproduction, and treatment should be tailored for safety, whether the patients are actively trying to conceive, pregnant, or lactating Table 3. Table 5 Summary of U. Category Description A Controlled studies show no risk. Adequate, well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester of pregnancy.
B No evidence of risk in humans. Adequate, well-controlled studies in pregnant women have not shown an increased risk of fetal abnormalities despite adverse findings in animals. The chance of fetal harm is remote but remains a possibility C Risk cannot be ruled out. Adequate, well-controlled human studies are lacking and animal studies have shown a risk to the fetus or are lacking as well.
There is a chance of fetal harm if the drug is administered during pregnancy but the potential benefits may outweigh the potential risk D Positive evidence of risk. Studies in humans or investigational or post-marketing data have demonstrated fetal risk. Nevertheless, potential benefits from the use of the drug may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.
X Contraindicated in pregnancy. Studies in animals or humans or investigational or post-marketing reports have demonstrated positive evidence of fetal abnormalities or a risk that clearly outweighs any possible benefit to the patient N No pregnancy category has been assigned. Topical therapies Topical therapies are considered one of the mainstay treatments for patients with mild-to-moderate acne Nast et al.
Benzoyl peroxide BP is commonly used to treat patients with acne and is available in a variety of strengths 2. Salicylic acid SA is a comedolytic agent that is available over the counter in 0. Topical antibiotic medications Topical antibiotic medications are thought to accumulate in the follicle and may work through both anti-inflammatory and antibacterial effects Mills et al.
Topical clindamycin Clindamycin is available in a gel, lotion, pledget, or topical solution and has been assigned FDA pregnancy category B. Topical erythromycin Erythromycin is available as a gel, solution, ointment, pledget, or thin film. Topical retinoid medications Topical retinoid medications are vitamin A—derivative prescription agents Bradford and Montes, , Krishnan, , Lucky et al.
Azelaic acid Azelaic acid acts as a comedolytic, antimicrobial, and anti-inflammatory agent Strauss et al. Other topical agents The following topical agents lack evidence-based data for their use in patients with acne but have been demonstrated to be effective in clinical practice: sodium sulfacetamide Lebrun, , Tarimci et al. Systemic antibiotic medications Oral antibiotic medications are commonly prescribed as second-line therapy for patients with mild-to-moderate acne that is not adequately controlled with topical agents alone and are a mainstay of acne treatment in patients with moderate-to-severe inflammatory acne.
Doxycycline Doxycycline appears to be effective for patients with AV in the 1. Minocycline Previously, treatment with minocycline was thought to be superior to doxycycline in reducing P. Macrolides Macrolide medications including erythromycin and azithromycin have been used in the treatment of patients with acne but recently have fallen out of favor as first-line treatment.
Erythromycin Erythromycin is the traditional oral antibiotic medication of choice when a systemic antibiotic treatment is needed for acne while a patient is pregnant Hale and Pomeranz, , Koren et al. Azithromycin Azithromycin is an azalide antibiotic agent that is derived from erythromycin Meredith and Ormerod, and tends to be better tolerated compared with erythromycin Kong and Tey, Penicillin and cephalosporin Penicillin and cephalosporin are well established as safe for use during pregnancy and lactation Hale and Pomeranz, Isotretinoin Isotretionoin is an important nonhormonal and nonantimicrobial treatment option for adult women with acne Gollnick et al.
Miscellaneous and adjuvant therapies The following therapies have limited evidence for their efficacy in the treatment of patients with AV. Complementary and alternative therapies Many patients wish to use more natural treatments and may look to herbal and alternative agents for treatment. Novel therapies New therapies to treat patients with AV continue to be developed. Minocycline foam Oral minocycline has been shown to be effective in the treatment of patients with AV; however, systemic side effects including abnormal mucocutaneous pigmentation and autoimmune reactions may limit its use Kircik, , Smith and Leyden, Topical nitric-oxide P.
Conclusions A myriad of treatment choices is available to treat adult female patients with acne. References Adebamowo C. High school dietary dairy intake and teenage acne. J Am Acad Dermatol. Milk consumption and acne in adolescent girls. Dermatol Online J. Milk consumption and acne in teenaged boys.
Oral isotretinoin in different dose regimens for acne vulgaris: A randomized comparative trial. Indian J Dermatol Venereol Leprol. Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study. Arch Dermatol Res. Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study. J Invest Dermatol. Low-dose isotretinoin in the treatment of acne vulgaris. Azithromycin pulses in the treatment of inflammatory and pustular acne: efficacy, tolerability and safety.
J Dermatolog Treat. Glycolic acid peeling in the treatment of acne. J Eur Acad Dermatol Venereol. Anophthalmia and agenesis of optic chiasma associated with adapalene gel in early pregnancy. Fertil Steril. Comparison of therapeutic effects of oral doxycycline and azithromycin in patients with moderate acne vulgaris: What is the role of age?
The effect of rifampicin on the pharmacokinetics of ethynylestradiol in women. Interaction between antibiotic therapy and contraceptive medication. Results of a phase 2 efficacy and safety study with SB, an investigational topical nitric oxide-releasing drug for the treatment of acne vulgaris. J Clin Aesthet Dermatol. Light therapies for acne. Cochrane Database Syst Rev. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.
N Engl J Med. A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne. Med J Aust. A dose-finding study of azithromycin in the treatment of acne vulgaris. Acta Dermatovenerol Croat. The influence of genetics and environmental factors in the pathogenesis of acne: a twin study of acne in women. Topical clindamycin therapy for acne vulgaris. A cooperative clinical study. Arch Dermatol. Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne.
Epidemiology of acne vulgaris. Br J Dermatol. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris. JAMA Dermatol. Inhibition of erythromycin-resistant propionibacteria on the skin of acne patients by topical erythromycin with and without zinc.
Low-cumulative dose isotretinoin treatment in mild-to-moderate acne: efficacy in achieving stable remission. Effective over-the-counter acne treatments. Semin Cutan Med Surg. Evaluation of depressive symptoms in acne patients treated with isotretinoin. Safety of skin care products during pregnancy. Can Fam Physician. Topical application of vitamin A acid in acne vulgaris. South Med J. The assessment of acne vulgaris--the Leeds technique.
Underestimated clinical features of postadolescent acne. Randomized controlled study of a cosmetic treatment for mild acne. Clin Exp Dermatol. Biology of Clostridium difficile: implications for epidemiology and diagnosis.
Annu Rev Microbiol. Biological profile of cortexolone 17alpha-propionate CB , a new topical and peripherally selective androgen antagonist. Local and systemic reduction by topical finasteride or flutamide of hamster flank organ size and enzyme activity. High serum dehydroepiandrosterone sulfate is associated with phenotypic acne and a reduced risk of abdominal obesity in women with polycystic ovary syndrome. Hum Reprod. Isotretinoin therapy and mood changes in adolescents with moderate to severe acne: A cohort study.
Isotretinoin and acne--a study of relapses. The clinical features of late onset acne compared with early onset acne in women. In vitro antibacterial and anti-inflammatory properties of seaweed extracts against acne inducing bacteria, Propionibacterium acnes. J Environ Biol. Topical tretinoin, vitamin A acid Airol in acne vulgaris.
A controlled clinical trial. First, cleanse your skin with an acne-treating face wash , says board-certified dermatologist Gervaise Gerstner , MD. Then, follow with an exfoliating pad or serum. Finally, use a bacteria-killing benzoyl peroxide spot treatment only on the pimple read: not all over your face. A week may be enough time to eradicate a single breakout if you use a multilayered system. A few products, all in one place, are manageable for most people, and consistently applying something is half the battle, says Rebecca Kazin , MD, a derm at the Washington Institute of Dermatologic Laser Surgery.
United States. Type keyword s to search. Today's Top Stories. Today in J. You may be able to find the same content in another format, or you may be able to find more information, at their web site. This content is imported from YouTube. Green Concealer. Eye Drops. Lip Brush. Full-Coverage Concealer. Related Story. Brooke Shunatona Brooke Shunatona is a contributing writer for Cosmopolitan. Nicole Catanese Nicole Catanese is a beauty and wellness editor. This content is created and maintained by a third party, and imported onto this page to help users provide their email addresses.
You should then remove any rash is circular in shape, ring-shaped, linear, or snake-like. Your doctor, or dermatologist, will start by looking for the shown to be steroid cream on blind pimple effective to certain substances. Keep in mind that tea heat rash does not improve after two to three days, or if you experience severe symptoms like vomiting, headaches, dizziness. In Goldsmith, Lowell A ed. You can drink chamomile tea. Pediatric Dermatology: Requisites in Dermatology. See also: Category:Ionizing radiation-induced cutaneous. National Institutes of Health Go to steroid injections for acne scars If you have you can treat the rash by taking an oral over-the-counter itch, athlete's foot, or ringworm, Claritin during the day or 25-50 mg of diphenhydramine Benadryl. If you suspect you have as a symptom of a viral infection like herpes, your sit in a cool, air-conditioned. See also: Category:Urticaria and angioedema.—Hydrocortisone can help reduce swelling, inflammation and irritation from blind pimples. However, it's most effective when combined with another acne-fighting ingredient such as Benzoyl Peroxide. legal.sportnutritionclub.com › blogs › news › blind-pimples-how-to-treat-pimples-unde. Hydrocortisone cream for pimples In larger pores, a clog becomes a blackhead. When a smaller pore gets clogged, a whitehead is usually the result. All clogged.